Tarsus Pharmaceuticals (TARS) Short Interest Ratio & Short Volume $54.70 -0.30 (-0.55%) (As of 05:27 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Tarsus Pharmaceuticals Short Interest DataTarsus Pharmaceuticals (TARS) has a short interest of 7.54 million shares. This marks a 5.01% increase in short interest from the previous month. The short interest ratio (days to cover) is 11.1, indicating that it would take 11.1 days of the average trading volume of 706,084 shares to cover all short positions.Current Short Interest7,540,000 sharesPrevious Short Interest7,180,000 sharesChange Vs. Previous Month+5.01%Dollar Volume Sold Short$395.85 millionShort Interest Ratio11.1 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares38,227,000 sharesPercentage of Shares Shorted19.72%Today's Trading Volume506,601 sharesAverage Trading Volume706,084 sharesToday's Volume Vs. Average72% Short Selling Tarsus Pharmaceuticals? Sign up to receive the latest short interest report for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTARS Short Interest Over TimeTARS Days to Cover Over TimeTARS Percentage of Float Shorted Over Time Ad DarwinMarket Winners Post-Election: Your Exclusive Report InsideThe dust has settled on the 2024 elections, and markets are already responding to the new political landscape. Now is the perfect time to adjust your strategy and take advantage of fresh opportunities emerging from these developments. We’re excited to share our updated report, “Post-Election Investment Gems: Top Stocks Set to Thrive in 2025.” This guide is designed to equip you with timely insights and actionable strategies in today’s evolving market.[Download your free report now] to stay ahead of the curve and uncover market opportunities you can’ Tarsus Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20247,540,000 shares $395.85 million +5.0%N/A11.1 $52.50 11/30/20247,180,000 shares $376.59 million +0.6%N/A10.4 $52.45 11/15/20247,140,000 shares $320.09 million -12.5%N/A9.7 $44.83 10/31/20248,160,000 shares $363.04 million -15.7%N/A11.2 $44.49 10/15/20249,680,000 shares $360.87 million -2.7%N/A13.5 $37.28 9/30/20249,950,000 shares $327.26 million +4.9%N/A14.2 $32.89 Get the Latest News and Ratings for TARS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tarsus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/20249,490,000 shares $315.64 million -3.1%N/A12.3 $33.26 8/31/20249,790,000 shares $265.41 million +2.6%N/A12.4 $27.11 8/15/20249,540,000 shares $257.20 million -2.3%N/A12.8 $26.96 7/31/20249,760,000 shares $237.07 million +10.8%N/A13.2 $24.29 7/15/20248,810,000 shares $246.68 million +4.1%N/A13.9 $28.00 6/30/20248,460,000 shares $229.94 million +6.3%N/A13.5 $27.18 6/15/20247,960,000 shares $246.60 million +6.4%N/A13.7 $30.98 5/31/20247,480,000 shares $246.54 million +0.1%N/A13.4 $32.96 5/15/20247,470,000 shares $287.60 million -2.5%N/A11.1 $38.50 4/30/20247,660,000 shares $240.75 million -3.0%N/A10.7 $31.43 4/15/20247,900,000 shares $276.03 million +0.6%N/A10.7 $34.94 3/31/20247,850,000 shares $285.35 million +9.0%N/A10.1 $36.35 3/15/20247,200,000 shares $227.38 million +19.4%N/A9.3 $31.58 2/29/20246,030,000 shares $230.47 million +6.5%N/A7.5 $38.22 2/15/20245,660,000 shares $178.57 million +4.2%N/A7.7 $31.55 1/31/20245,430,000 shares $147.91 million +8.2%N/A7.7 $27.24 1/15/20245,020,000 shares $110.94 million +0.4%N/A7.9 $22.10 12/31/20235,000,000 shares $101.25 million +1.8%N/A8.2 $20.25 12/15/20234,910,000 shares $93.54 million +10.3%N/A8.3 $19.05 11/30/20234,450,000 shares $73.56 million -0.2%N/A8.1 $16.53 11/15/20234,460,000 shares $79.97 million +6.2%N/A9.2 $17.93 10/31/20234,200,000 shares $59.81 million +5.0%N/A10.1 $14.24 10/15/20234,000,000 shares $51.92 million -19.4%N/A7.6 $12.98 9/30/20234,960,000 shares $88.14 million +13.0%N/A10.2 $17.77 9/15/20234,390,000 shares $70.85 million -2.7%N/A10.1 $16.14 8/31/20234,510,000 shares $78.97 million +0.7%N/A10.8 $17.51 8/15/20234,480,000 shares $76.16 million +17.9%N/A11.3 $17.00 7/31/20233,800,000 shares $83.64 million +65.9%N/A9.9 $22.01 7/15/20232,290,000 shares $40.42 million +2.2%13.0%10.7 $17.65 6/30/20232,240,000 shares $40.48 million +42.7%11.4%11 $18.07 6/15/20231,570,000 shares $29.23 million +72.6%8.0%7.8 $18.62 5/31/2023909,800 shares $15.24 million +6.8%4.7%5.5 $16.75 5/15/2023852,000 shares $14.11 million -11.3%4.4%6.2 $16.56 4/30/2023960,800 shares $14.34 million +0.2%5.0%8.7 $14.92Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 4/15/2023959,400 shares $11.10 million -3.3%5.0%9.3 $11.57 3/31/2023991,600 shares $12.46 million -4.7%5.2%12 $12.57 3/15/20231,040,000 shares $14.29 million +4.3%5.4%14.2 $13.74 2/28/2023996,700 shares $15.44 million +1.1%5.4%12 $15.49 2/15/2023985,900 shares $15.12 million +1.8%5.3%11.2 $15.34 1/31/2023968,800 shares $15.27 million -6.9%5.1%9.9 $15.76 1/15/20231,040,000 shares $15.12 million No Change5.5%9.7 $14.54 12/30/20221,040,000 shares $15.25 million +19.0%6.1%10.9 $14.66 12/15/2022874,300 shares $12.91 million -28.9%5.1%9.1 $14.77 11/30/20221,230,000 shares $20.68 million -3.2%7.2%12.8 $16.81 11/15/20221,270,000 shares $22.61 million -14.8%7.4%13.7 $17.80 10/31/20221,490,000 shares $27.45 million -0.7%8.9%16.6 $18.42 10/15/20221,500,000 shares $25.47 million +0.7%9.0%17.5 $16.98 9/30/20221,490,000 shares $25.51 million +19.2%8.9%17.4 $17.12 9/15/20221,250,000 shares $19.96 million No Change7.5%11.1 $15.97 8/31/20221,250,000 shares $19.23 million No Change7.5%10.6 $15.38 8/15/20221,250,000 shares $22.99 million -1.6%7.5%8.6 $18.39 7/31/20221,270,000 shares $19.08 million -3.8%7.7%6.9 $15.02 7/15/20221,320,000 shares $19.34 million +8.2%8.0%5.6 $14.65 6/30/20221,220,000 shares $17.81 million +91.4%7.4%5.2 $14.60 6/15/2022637,400 shares $8.34 million +45.9%3.9%2.8 $13.09 5/31/2022437,000 shares $6.01 million +13.0%2.6%2.4 $13.75 5/15/2022386,800 shares $5.08 million -32.2%2.3%2.6 $13.13 4/30/2022570,200 shares $10.44 million -3.0%5.9%5.1 $18.31 4/15/2022587,800 shares $10.80 million +7.3%6.1%14 $18.38 3/31/2022548,000 shares $9.22 million +35.4%5.7%14.2 $16.82 3/15/2022404,600 shares $7.17 million +4.7%4.2%11.4 $17.71 2/28/2022386,400 shares $6.81 million +10.0%4.0%13.2 $17.63 2/15/2022351,200 shares $5.62 million +6.3%3.6%11.9 $16.00 1/31/2022330,300 shares $6.63 million +2.3%3.4%11.6 $20.07 1/15/2022322,900 shares $6.70 million -0.7%3.3%12.2 $20.75 12/31/2021325,200 shares $7.32 million 0.0%3.4%10.9 $22.50 12/15/2021325,300 shares $8.57 million +2.7%3.4%10.9 $26.34 11/30/2021316,700 shares $8.42 million +1.3%3.3%10.5 $26.60 11/15/2021312,600 shares $7.99 million -3.3%3.3%10.1 $25.56 10/29/2021323,100 shares $8.97 million -2.3%3.5%11.8 $27.76 10/15/2021330,800 shares $9.43 million +0.6%3.5%11 $28.52 9/30/2021329,000 shares $7.09 million +0.2%3.5%11.9 $21.55 9/15/2021328,400 shares $7.16 million +7.5%3.5%9.3 $21.81 8/31/2021305,400 shares $8.09 million -1.7%3.3%5.6 $26.50 8/13/2021310,800 shares $8.07 million -2.4%3.3%5.3 $25.98 7/30/2021318,500 shares $7.19 million -2.7%3.6%5 $22.57 7/15/2021327,200 shares $8.43 million +3.1%3.7%4.7 $25.76 6/30/2021317,500 shares $9.20 million +12.8%3.6%4.5 $28.98 6/15/2021281,400 shares $9.92 million -10.4%3.3%4.2 $35.26 5/28/2021314,000 shares $10.46 million -15.4%3.7%6.6 $33.32 5/14/2021371,100 shares $10.99 million -3.3%4.3%8.3 $29.62 4/30/2021383,600 shares $11.58 million +0.1%4.5%9.1 $30.20 4/15/2021383,400 shares $11.51 million -5.6%4.5%11.5 $30.01 3/31/2021406,300 shares $11.50 million +3.2%4.8%11.1 $28.30Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. 3/15/2021393,800 shares $13.19 million +6.6%4.7%5.2 $33.50 2/26/2021369,400 shares $13.87 million +5.9%4.4%4.2 $37.56 2/12/2021348,800 shares $12.82 million +34.1%4.2%3.8 $36.76 1/29/2021260,200 shares $10.13 million +2.9%3.1%2.8 $38.92 1/15/2021253,000 shares $11.11 million No Change3.0%2.5 $43.91 TARS Short Interest - Frequently Asked Questions What is Tarsus Pharmaceuticals' current short interest? Short interest is the volume of Tarsus Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of December 15th, traders have sold 7,540,000 shares of TARS short. Learn More on Tarsus Pharmaceuticals' current short interest. What is a good short interest ratio for Tarsus Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TARS shares currently have a short interest ratio of 11.0. Learn More on Tarsus Pharmaceuticals's short interest ratio. Is Tarsus Pharmaceuticals' short interest increasing or decreasing? Tarsus Pharmaceuticals saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 7,540,000 shares, an increase of 5.0% from the previous total of 7,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Tarsus Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tarsus Pharmaceuticals: Revolution Medicines, Inc. (9.84%), Lantheus Holdings, Inc. (6.73%), Legend Biotech Co. (12.57%), Nuvalent, Inc. (11.35%), Elanco Animal Health Incorporated (3.16%), Cytokinetics, Incorporated (12.09%), Blueprint Medicines Co. (7.13%), BridgeBio Pharma, Inc. (11.59%), TG Therapeutics, Inc. (19.32%), Crinetics Pharmaceuticals, Inc. (6.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Tarsus Pharmaceuticals stock? Short selling TARS is an investing strategy that aims to generate trading profit from Tarsus Pharmaceuticals as its price is falling. TARS shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tarsus Pharmaceuticals? A short squeeze for Tarsus Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TARS, which in turn drives the price of the stock up even further. How often is Tarsus Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TARS, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies Revolution Medicines Short Interest Lantheus Short Interest Legend Biotech Short Interest Nuvalent Short Interest Elanco Animal Health Short Interest Cytokinetics Short Interest Blueprint Medicines Short Interest BridgeBio Pharma Short Interest TG Therapeutics Short Interest Crinetics Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TARS) was last updated on 12/30/2024 by MarketBeat.com Staff From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | Sponsored>>>RE: Buy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
